KMTS vs TECH · rev $59.8M vs P/E 65, rev $1.22B
Kestra Medical Technologies, Ltd. Common Stock (KMTS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a medical instruments & supplies company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported KMTS revenue for 2025-04-30 was $59.8M. Net income was -$113.8M. Revenue was up 115.1% from 2024-04-30 to 2025-04-30. KMTS currently screens at market cap $1.24B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
KMTS currently screens at market cap $1.24B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the KMTS and TECH stock pages for the full models.
Not investment advice.